Validation of the Stability of Diagnostic Biomarkers on Healthy Volunteers
NCT05160337 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2025-07-25
Summary
Stability studies on the peripheral biomarkers (lncRNAs, sncRNAs, mRNAs, proteins, lipids/metabolites) measured by Firalis IVD test candidates and effect of gender, age, nutrition on their expression level
Conditions
- Healthy
Interventions
- DIAGNOSTIC_TEST
-
Biomarker based IVD tests
Biomarker based IVD tests
Sponsors & Collaborators
-
Firalis SA
lead INDUSTRY
Principal Investigators
-
Pierre Rohrlich, MD,Phd · Firalis SA
-
Hueseyin Firat, MD, PhD, HDR · Firalis SA
-
Stephanie Boutillier, PhD · Firalis SA
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-06-18
- Primary Completion
- 2026-08-31
- Completion
- 2027-04-30
Countries
- France
Study Locations
More Related Trials
-
Circulating Biomarker Signatures for the Detection of Gastric Preneoplasia and Cancer
NCT05854368 ·Status: RECRUITING ·Phase: NA
-
Prospective Study to Assess a Diagnostic Aid for Cancer
NCT07046260 ·Status: RECRUITING
-
IDENTIFY Study: Natural History of Maternal Neoplasia
NCT04049604 ·Status: RECRUITING ·Phase: NA
-
Analysis of Circulating Tumor Markers in Blood
NCT04025541 ·Status: RECRUITING ·Phase: NA
-
Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma
NCT01334008 ·Status: COMPLETED ·Phase: NA
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN
-
Evaluation of ClearLLab LS Screening Panel
NCT05819762 ·Status: COMPLETED
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Biomarkers of Renal Dysfunction in Neuroblastoma Survivors
NCT03947346 ·Status: COMPLETED
-
Evaluation of Fibrin Structure Marker in Cancer Patients Treated and Not Treated With LMWH
NCT02552381 ·Status: COMPLETED
-
Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
NCT01187602 ·Status: UNKNOWN
-
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments
NCT00586417 ·Status: TERMINATED ·Phase: NA
-
Research Into Biomarkers Predictive of Survival and Response to Cancer Treatment
NCT06851975 ·Status: RECRUITING ·Phase: NA
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer
NCT03892096 ·Status: COMPLETED
-
STRucturation of Transcript Analysis of Genes Involved in Hereditary Cancers
NCT06861621 ·Status: RECRUITING
-
Sentinel™ Trial: A Prospective Study Evaluating the Performance and Clinical Benefit of Personalized ctDNA-based MRD Testing to Detect Recurrence and Monitor Treatment Response in Patients With Solid Tumors
NCT05082701 ·Status: TERMINATED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
NCT03662204 ·Status: COMPLETED
-
Liquid Biopsies for the Personalized Management of Patients with Hereditary Diffuse Gastric Cancer
NCT04253106 ·Status: COMPLETED ·Phase: NA
-
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
NCT06341855 ·Status: RECRUITING ·Phase: NA
-
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT05181826 ·Status: RECRUITING
-
Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.
NCT04456972 ·Status: COMPLETED ·Phase: NA
-
Implementing Precision Medicine in cOmmunity HospiTALs
NCT05283044 ·Status: RECRUITING ·Phase: NA
-
Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer
NCT05991947 ·Status: RECRUITING
-
Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology
NCT02220556 ·Status: COMPLETED ·Phase: NA